Good Sense Nicotine

Product NDC: 0113-0734
11-digit product format: 001130734
Labeler code: 0113
Product ID: 0113-0734_d653d9ea-04f7-46eb-a74a-ee8a5e0d3ba0
Type: HUMAN OTC DRUG
Nonproprietary name: Nicotine Polacrilex
Dosage form: LOZENGE
Route: ORAL
Labeler: L. Perrigo Company
Application: ANDA203690
Marketing category: ANDA
Marketing start: 2013-04-22
Substance: NICOTINE
Active strength: 2 mg/1
Pharmacologic classes: Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0113-0734	0113-0734-03	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A203690-001	NICOTINE POLACRILEX	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL			2012-10-09
A203690-002	NICOTINE POLACRILEX	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL			2012-10-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`74a2ff9319b5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Good Sense Nicotine
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NICOTINE	2 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6M3C89ZY6R	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
359817	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
477689fc-688a-4c76-8c02-35a7a15adc5e	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508
dbebfdf8-6e0c-cfa8-fdbc-e5d7f1bf1562	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0113-0734-01	Good Sense Nicotine	27 in 1 CONTAINER	LOZENGE	27	7
0113-0734-02	Good Sense Nicotine	3 in 1 CARTON	LOZENGE	3	7
0113-0734-03	Good Sense Nicotine	27 in 1 CONTAINER	LOZENGE	27	7
0113-0734-03	Good Sense Nicotine	4 in 1 CARTON	LOZENGE	4	7
0113-0734-04	Good Sense Nicotine	5 in 1 CARTON	LOZENGE	5	7
0113-0734-07	Good Sense Nicotine	8 in 1 CARTON	LOZENGE	8	7
0113-0734-60	Good Sense Nicotine	20 in 1 CONTAINER	LOZENGE	20	7
0113-0734-60	Good Sense Nicotine	1 in 1 CARTON	LOZENGE	1	7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0113-0734-02	EA - Each	0113-0734	a61a3094-4524-4522-ba7d-9027cfb4313b	1	2017-12-14
0113-0734-60	EA - Each	0113-0734	980ddbf2-f0b6-4e63-b400-73877b9bee2c	1	2023-01-09

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
NICOTINE	ACTIVE INGREDIENT	6M3C89ZY6R	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
NICOTINE	ACTIVE MOIETY	6M3C89ZY6R	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
ACESULFAME POTASSIUM	INACTIVE INGREDIENT	23OV73Q5G9	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
CALCIUM POLYCARBOPHIL	INACTIVE INGREDIENT	8F049NKY49	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
POLACRILIN	INACTIVE INGREDIENT	RCZ785HI7S	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
POTASSIUM BICARBONATE	INACTIVE INGREDIENT	HM5Z15LEBN	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
SODIUM ALGINATE	INACTIVE INGREDIENT	C269C4G2ZQ	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
SODIUM CARBONATE	INACTIVE INGREDIENT	45P3261C7T	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0113-0734	GOOD SENSE NICOTINE (NICOTINE POLACRILEX) LOZENGE [L. PERRIGO COMPANY]	6	Current NDC, Legacy NDC, 8 package rows	20240702_477689fc-688a-4c76-8c02-35a7a15adc5e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 5 · 83 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
members mark Nicotine	NICOTINE POLACRILEX	Sam's West Inc	c31c30b9-7431-4b90-b011-f34e499df192	2025-11-15	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
nicotine mini	NICOTINE POLACRILEX	Walgreen Company	33e456bb-1d5d-4b06-8f06-8bb4eab5b1fd	2025-10-02	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
members mark nicotine	NICOTINE POLACRILEX	Sam's West Inc	d185b5e7-9bb1-4d16-b146-1fbfba874053	2025-09-16	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
foster and thrive nicotine	NICOTINE POLACRILEX	Strategic Sourcing Services LLC	7b1b5f6e-c5ee-48fc-85ee-2e11c30213e4	2025-09-16	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
nicotine	NICOTINE POLACRILEX	Kroger Company	0b1874bd-f908-485a-b045-7d0050be7bb2	2025-09-13	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Basic Care Nicotine	NICOTINE POLACRILEX	Amazon.com Services LLC	03b27d95-f2cb-43d4-9bc3-55ea66fadb0d	2025-09-13	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
mini nicotine	NICOTINE POLACRILEX	Meijer Distribution Inc	426b2f92-561d-476b-959c-cdd0fa37be56	2025-09-12	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
equate nicotine	NICOTINE POLACRILEX	Wal-Mart Stores Inc	04f2b325-2243-4c6f-880c-45f2543091da	2025-09-12	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Nicotine Polacrilex	NICOTINE POLACRILEX	Bryant Ranch Prepack	c2627853-945b-42d8-8351-39028e513d77	2025-07-29	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Nicotine Polacrilex	NICOTINE POLACRILEX	Bryant Ranch Prepack	16ece78d-c66e-43c1-953a-f774797ae097	2025-07-29	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Nicotine Polacrilex	NICOTINE POLACRILEX	Bryant Ranch Prepack	094de23b-d433-487d-8364-6f245c8117c6	2025-04-03	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Nicotine Polacrilex	NICOTINE POLACRILEX	Bryant Ranch Prepack	3997dda6-89ea-49df-abda-ab420327a473	2025-04-03	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
nicotine mini	NICOTINE POLACRILEX	Walgreen Company	4a08b910-5479-49f5-abbe-ca68949efb24	2024-08-22	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
CareOne Mini Nicotine Polacrilex	NICOTINE POLACRILEX	American Sales Company	d3591f0c-f638-485a-ab34-f71fce6a966f	2023-10-25	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
nicotine	NICOTINE POLACRILEX	Walgreen Company	8af06c23-80b7-4559-b594-a3a02297306d	2023-05-28	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Equate Nicotine	NICOTINE POLACRILEX	Wal-Mart Stores Inc	8c66eb21-dd95-4dcb-8488-e1e768dd8cd6	2022-12-06	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Rexall Nicotine	NICOTINE POLACRILEX	Dolgencorp, LLC	83b053f6-304b-4f9c-8a6d-6649998708b2	2021-12-15	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Nicotine	NICOTINE POLACRILEX	Meijer Distribution Inc	dc70703e-2c55-4178-a5d5-50f762ab6492	2019-04-24	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Nicotine	NICOTINE POLACRILEX	Meijer Distribution Inc	1d2cfb36-2d94-468c-8da1-6b6999b07d7b	2019-04-18	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
signature care nicotine	NICOTINE POLACRILEX	Safeway	22010ed8-7fa6-402a-a314-523538183a55	2018-11-01	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6M3C89ZY6R	NICOTINE	54-11-5	NICOTINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
359817	nicotine 2 MG Oral Lozenge	PSN	477689fc-688a-4c76-8c02-35a7a15adc5e	7
359817	nicotine 2 MG Oral Lozenge	SCD	477689fc-688a-4c76-8c02-35a7a15adc5e	7
359817	nicotine 2 MG (as nicotine polacrilex 11.1 MG) Oral Lozenge	SY	477689fc-688a-4c76-8c02-35a7a15adc5e	7
359817	nicotine 2 MG Troche	SY	477689fc-688a-4c76-8c02-35a7a15adc5e	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0113-0734-01	00113073401	27 in 1 CONTAINER						Historical
0113-0734-02	00113073402	3 CONTAINER in 1 CARTON (0113-0734-02) / 27 LOZENGE in 1 CONTAINER (0113-0734-01)	3 container	2013-04-22	0000-00-00	No	No	Current
0113-0734-03	00113073403	4 CONTAINER in 1 CARTON (0113-0734-03) > 27 LOZENGE in 1 CONTAINER	4 container	2013-04-22	0000-00-00	No	No	Current
0113-0734-04	00113073404	5 CONTAINER in 1 CARTON (0113-0734-04) / 27 LOZENGE in 1 CONTAINER (0113-0734-01)	5 container	2024-06-21		No	No	Current
0113-0734-07	00113073407	8 CONTAINER in 1 CARTON (0113-0734-07) / 27 LOZENGE in 1 CONTAINER (0113-0734-01)	8 container	2024-06-21		No	No	Current
0113-0734-60	00113073460	1 CONTAINER in 1 CARTON (0113-0734-60) / 20 LOZENGE in 1 CONTAINER	1 container	2018-03-26	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Perrigo Nicotine Polacrilex Lozenge 2 mg (nicotine) Drug Facts	L. Perrigo Company	2025-11-19	HUMAN OTC DRUG LABEL	7